RxDoctor Payments Data

Deanna Winter

Nurse Practitioner · Edgewood, KYNPI 1043268170

Payments from drug & device makers

$1,996in general payments, 2019–2025

Across 107 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$292
  • Johnson & Johnson$237
  • Pfizer$213
  • Bayer$160
  • Biosense Webster, Inc.$145
  • Boston Scientific$140
  • plus $809 from 18 others

What the payments were for

  • Food & beverage$1,996100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,996 in reported general payments places this provider in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$34,781
Medicare patients
299
Services billed
526

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban330$287,065
XareltoRivaroxaban33$21,152
Metoprolol Succinate206$3,008
Flecainide Acetate61$2,063
SotalolSotalol Hcl109$2,027
Bisoprolol Fumarate138$1,742
Amiodarone Hcl110$1,623
Diltiazem 24hr Er (Cd)Diltiazem Hcl53$1,545
Mexiletine Hcl13$1,240
Olmesartan Medoxomil19$594
Metoprolol Tartrate67$481
Carvedilol64$427
Diltiazem 24hr ErDiltiazem Hcl13$309
Digoxin12$129
Amlodipine Besylate20$124

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$213$287,065330 claims
Johnson & JohnsonXarelto$237$21,15233 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Edgewood

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →